A new study published in the Journal of Allergy and Clinical Immunology showed that adults who used nasal and inhaled corticosteroids had a higher risk of contracting SARS-CoV-2, but not children.
The respiratory virus that caused the COVID-19 pandemic, SARS-CoV-2, usually first infects the upper respiratory tract (URT). The successful entrance of SARS-CoV-2 into the URT cells and the development of infection can be influenced by certain host variables after airborne exposure. For the long-term treatment of asthma and allergic rhinitis, topical airway corticosteroids—like nasal [NCS] or inhaled corticosteroids [ICS]—are the cornerstone of care.
Studies predict that the risk of SARS-CoV-2 infection varies among people who use topical airway corticosteroids when compared to those who do not take these routinely used drugs because they may affect the SARS-CoV-2 URT cell entry mechanism and acute immune response. Thus, this study was set to investigate the relationships between the usage of ICS and NCS and the risk of SARS-CoV-2 infection in people with asthma or allergic rhinitis.
This surveillance research was carried out in child-bearing homes. The participants had nasal swabs taken every 2 weeks, with extra samples made in response to COVID-19-related symptoms.
Using Cox proportional hazard regression, researchers investigated the relationship between the time to the first SARS-CoV-2 positive quantitative PCR test and the usage of NCS or ICS at study entrance (in patients with asthma or allergic rhinitis, respectively).
Nearly, 1,113 homes with 2,211 people were included. Age altered the relationships between NCS and ICS usage and SARS-CoV-2 infection risk (p for both interactions<0.05).
Higher odds of SARS-CoV-2 infection in adults were linked to both NCS and ICS usage separately (adjusted hazard ratio [aHR]=1.88, 95% CI=1.14-3.12, p=0.01, and aHR=2.15, 95% CI=1.003-4.63, p=0.049, respectively).
A number of sensitivity studies consistently found a link between NCS usage and the probability of SARS-CoV-2 infection in adults.
Neither NCS nor ICS usage was linked to a child's chance of contracting SARS-CoV-2.
Overall, in accordance with this research, adults who use NCS have a higher chance of contracting SARS-CoV-2 than children do. Age-dependent results for ICS usage were similar, but less stable.
Reference:
Rosas-Salazar, C., Gebretsadik, T., Seibold, M. A., Moore, C. M., Arbes, S. J., Bacharier, L. B., Brunwasser, S. M., Camargo, C. A., Jr, Dupont, W. D., Furuta, G. T., Gruchalla, R. S., Gupta, R. S., Jackson, D. J., Johnson, C. C., Kattan, M., Khurana Hershey, G. K., Liu, A. H., O’Connor, G. T., Phipatanakul, W., … HEROS Study Group. (2025). Impact of nasal and inhaled corticosteroids on SARS-CoV-2 infection susceptibility. The Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2025.07.006
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.